Condition
BRAF V600E Mutation Positive clinical trials and research
As of November 12, 2026, Find a Trial lists 4 BRAF V600E Mutation Positive clinical trials that are recruiting, at sites in 2 countries (most in France (2), China (2)). By phase: Phase 2 (3). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 2Countries
Newest BRAF V600E Mutation Positive clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Neoadjuvant therapy with encorafenib plus cetuximab N01 and mFOLFOX6 in locally advanced BRAF V600E-mutant colorectal cancer | Phase 2 | Hangzhou, Zhejiang | Recruiting | Aug 27, 2026 |
| Neoadjuvant targeted therapy for ameloblastoma | Phase 2 | Shanghai, Shanghai Municipality | Recruiting | Oct 22, 2024 |
| Combination treatment for localized colon or upper rectum cancer with BRAF mutation | Phase 2 | Paris | Recruiting | Jan 31, 2023 |
| Collecting data from patients with BRAFV600E-mutated metastatic colorectal cancer | — | Avignon and 44 other locations | Recruiting | Dec 6, 2022 |
All recruiting trials (4)
-
Neoadjuvant therapy with encorafenib plus cetuximab N01 and mFOLFOX6 in locally advanced BRAF V600E-mutant colorectal cancer
This trial tests a targeted, pre-surgery treatment to see if it improves the chance of long-term control in adults with locally advanced BRAF V600E-mutant colorectal cancer.
-
Neoadjuvant targeted therapy for ameloblastoma
This study is testing if a new targeted therapy can help patients with a specific type of jaw tumor called ameloblastoma have less invasive surgery instead of more extensive surgery.
-
Combination treatment for localized colon or upper rectum cancer with BRAF mutation
This study is testing a combination treatment of encorafenib and cetuximab for patients with localized colon or upper rectal cancer that has a specific BRAF mutation to see if it helps before surgery.
-
Collecting data from patients with BRAFV600E-mutated metastatic colorectal cancer
This study is collecting information and samples from patients with a specific type of metastatic colorectal cancer to see how well different treatments work and what factors affect their outcomes.
Related topics
Quick answers
How many BRAF V600E Mutation Positive clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in France (2 trials), China (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.